Skip to content

FARMAFLEUR

Active
Private limited companyfounded 200718 yrs activeOosterlinckhoflaan 48, 2180 Antwerpen, BelgiumKBO/BCE: BE 0894.786.891

FARMAFLEUR has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €180k and a net result of €62k. Equity remains stable across the filed fiscal years (±0.1% per year). Its solvency ranks better than 43% of 10253 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
69 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82=
Solvency56▼-2
Growth58=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 1.59 against 1.89 in 2024; short-term debt: 45.1% and cash: 23.5% of total assets), but 69.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 18 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
30.7%
Return on assets
10.6%
Age of the figures
18 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 24-10-2025, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 d early
2024
1 d early
2023
1 d early
2022
2 d late
2021
30 d late
2020
16 d late
2019
on the day
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven months
Position in the running window
31-03-2026 close16-09-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€180k▲ 0.3%
2024 · €180k
2019: €182k 2020: €182k 2021: €178k 2022: €179k 2023: €179k 2024: €180k
2019 → 2025
Total assets
€587k▲ 6.8%
2024 · €549k
2019: €482k 2020: €495k 2021: €457k 2022: €451k 2023: €606k 2024: €549k
2019 → 2025
Net result
€62k▲ 7.7%
2024 · €58k
2019: €11k 2020: €24k 2021: €-4k 2022: €50k 2023: €71k 2024: €58k
2019 → 2025
Working capital
€156k▼ 10.1%
2024 · €173k
2019: €231k 2020: €236k 2021: €214k 2022: €196k 2023: €171k 2024: €173k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€178k-€179k▲ 0.3%€179k▲ 0.5%€180k▲ 0.3%€180k▲ 0.3%
Operating result€951-€57k▲ 5,845%€77k▲ 37.0%€65k▼ 15.5%€70k▲ 7.3%
Net result€-4k-€50k€71k▲ 43.0%€58k▼ 18.2%€62k▲ 7.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-25k€0€25k€50k€75kOperating result 2021: €951€951Net result 2021: €-4k€-4kOperating result 2022: €57k€57kNet result 2022: €50k€50kOperating result 2023: €77k€77kNet result 2023: €71k€71kOperating result 2024: €65k€65kNet result 2024: €58k€58kOperating result 2025: €70k€70kNet result 2025: €62k€62k20212022202320242025
The operating result recovers in 2025; 2025 is 7% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €587k
Fixed assets €166k▼ 8.3%
Current assets €420k▲ 14.2%
Equity and liabilities €587k
Equity €180k▲ 0.3%
Debt €406k▲ 10.0%
The debt ratio rises from 67.3% to 69.3%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€103k
2024 · €96k
Cash flow
€95k
2024 · €89k
Solvency
30.7%
2024 · 32.7%
Current ratio
1.59
2024 · 1.89
Quick ratio
0.79
2024 · 0.89
Debt / equity
2.25
2024 · 2.05
ROE
34.6%
2024 · 32.2%
ROA
10.6%
2024 · 10.6%
Interest coverage
23.50
2024 · 17.67
Debt
€406k
2024 · €370k
Debt ≤ 1 year
€264k
2024 · €195k
Debt > 1 year
€142k
2024 · €172k
Income taxes
€4k
2024 · €2k
Staff costs
€77k
2024 · €73k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€549k€587k
Fixed assets21/28€181k€166k
Tangible fixed assets22/27€181k€166k
Land and buildings22€110k€98k
Plant, machinery and equipment23€13k€26k
Furniture and vehicles24€58k€43k
Current assets29/58€368k€420k
Stocks and contracts in progress3€195k€211k
Stocks30/36€195k€211k
Amounts receivable within one year40/41€97k€66k
Trade receivables40€89k€55k
Other amounts receivable41€8k€10k
Cash at bank and in hand54/58€72k€138k
Deferred charges and accrued income490/1€5k€5k
Equity and liabilities
Total equity and liabilities10/49€549k€587k
Equity10/15€180k€180k
Contributions10/11€19k€19k=
Reserves13€161k€162k
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Tax-exempt reserves132€31€31=
Distributable reserves133€161k€162k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€370k€406k
Amounts payable after more than one year17€172k€142k
Financial debts170/4€172k€142k
Amounts payable within one year42/48€195k€264k
Current portion of amounts payable after more than one year42€30k€30k
Trade debts44€51k€72k
Suppliers440/4€51k€72k
Taxes, remuneration and social security45€12k€13k
Taxes450/3€171€4k
Remuneration and social security454/9€12k€9k
Other amounts payable47/48€102k€149k
Accrued charges and deferred income492/3€3k€0
Income statement Code20242025
Remuneration, social security and pensions62€73k€77k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€31k€33k
Other operating charges640/8€4k€2k
Gross operating margin9900€174k€181k
Operating profit (loss)9901€65k€70k
Financial income75/76B€192€278
Recurring financial income75€192€278
Financial charges65/66B€5k€4k
Recurring financial charges65€5k€4k
Profit (loss) for the period before taxes9903€60k€66k
Income taxes67/77€2k€4k
Profit (loss) for the period9904€58k€62k
Profit (loss) for the period to be appropriated9905€58k€62k
Appropriation of the result
Profit (loss) to be appropriated9906€58k€62k
Transfer to equity691/2€475€452
To other reserves6921€475€452
Profit to be distributed694/7€58k€62k
Directors or managers695€58k€62k
Social balance
Average headcount (FTE)90872.12.0

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2025
24-10
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2024
30-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2023
30-10
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
31-03
Financial Highest result since 2019net €71k ▲43%
Operating result €77k, net result €71k, both a record.
2022
02-11
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 2 days late
31-03
Financial Back to profitnet €50k
Net result €50k after one loss-making year.
2021
30-11
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 30 days late
31-03
Financial Weakest financial yearnet €-4k ▼117%
Net result drops to €-4k, the lowest in the series; recovery starts the following year.
2020
16-11
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 16 days late
2019
31-10
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
31-10
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
27-10
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
27-10
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2008
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Oosterlinckhoflaan 482180 Antwerpen
Ground area
461 m²
Building footprint
164 m²
Volume, LiDAR
870 m³
Parcel 11364F0293/00W011, Flanders · tallest building 10.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apodroom-Peeters
Oosterlinckhoflaan 48, 2180 AntwerpenRetail sale of pharmaceutical products
since 20082.168.483.005
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11364F0293/00W011 Flanders 461 m² 1 · 164 m² 10.3 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,583 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-12-2007
Fiscal year end31-03
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.